238. Vitamin D-resistant rickets Clinical trials / Disease details
Clinical trials : 28 / Drugs : 20 - (DrugBank : 9) / Drug target genes : 3 - Drug target pathways : 16
| No. | TrialID | Date_ enrollment | Date_ registration | Public_title | Scientific_title | Condition | Intervention | Primary_ sponsor | Secondary_ sponsor | Recruitment_ Status | Inclusion_ agemin | Inclusion_ agemax | Inclusion_ gender | Target_ size | Phase | Countries |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | NCT00417612 (ClinicalTrials.gov) | January 2007 | 28/12/2006 | Effectiveness of Paricalcitol in Reducing Parathyroid Hormone (PTH) Levels in X-linked Hypophosphatemic Rickets | The Role of Parathyroid Hormone in the Pathogenesis of Skeletal Disease in X-linked Hypophosphatemic Rickets (XLH) | Hypophosphatemia, Familial;Hyperparathyroidism | Drug: Paricalcitol;Other: Placebo | Yale University | National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS) | Completed | 9 Years | N/A | All | 33 | Phase 3 | United States |